Vandria
Lausanne, CH · Founded 2021 · 16 employees on LinkedIn · 2 known investors
Find your way into Vandria
43 people in our graph share verified history with the Vandria team — schools, employers, funds. One of them is your warm intro.
Gabriela Eccounlockedknows Klaus Dugi · together at Vandria (overlapped)
×2knows the team · via Vandria
×4knows the team · via Ferring Pharmaceuticals
×5knows the team · via +ND Capital
Vandria is a pharmaceutical development company focused on translating scientific innovation into first-in-class therapeutics. The company's management team specializes in mitochondrial function and neurological disease treatment.
Founders & leadership
Vandria was founded in 2021 by Patrick Aebischer and Pénélope Andreux.
PA
Patrick AebischerCo-founder
PA
Pénélope AndreuxinHead of Research (mitochondrial research and development)
KD
Klaus DugiinChief Medical Officer / Medical LeadershipChief Medical Advisor & Venture Partner at +ND Capital
P
PeterBusiness Development & Entrepreneurship Leadership
L
LeilaOperations Leadership
AP
Anke PostChief Medical Officer / Neuroscience Leadership
GE
Guillermo EliasChief Executive Officer
Investors · 2
Funding
SEC filings, press & company announcements$30.7M disclosed across 1 of 2 rounds · 2023–2024
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Vandria do?
- Vandria is a pharmaceutical development company focused on translating scientific innovation into first-in-class therapeutics. The company's management team specializes in mitochondrial function and neurological disease treatment.
- Who founded Vandria?
- Vandria was founded by Patrick Aebischer, Pénélope Andreux in 2021.
- Who are Vandria's investors?
- Vandria's investors include +ND Capital, Dolby Family Ventures.
- How much funding has Vandria raised?
- Vandria has disclosed $30.7M raised across 1 of its 2 known rounds.
- Where is Vandria headquartered?
- Vandria is headquartered in Lausanne, CH.